Free Trial

Holocene Advisors LP Takes Position in Innospec Inc. (NASDAQ:IOSP)

Innospec logo with Basic Materials background

Holocene Advisors LP bought a new position in Innospec Inc. (NASDAQ:IOSP - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,123 shares of the specialty chemicals company's stock, valued at approximately $1,258,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in IOSP. Inspire Advisors LLC increased its stake in shares of Innospec by 1.6% in the second quarter. Inspire Advisors LLC now owns 6,819 shares of the specialty chemicals company's stock valued at $843,000 after buying an additional 110 shares during the period. Arizona State Retirement System increased its stake in shares of Innospec by 1.9% in the second quarter. Arizona State Retirement System now owns 6,962 shares of the specialty chemicals company's stock valued at $860,000 after buying an additional 128 shares during the period. Texas Permanent School Fund Corp increased its stake in shares of Innospec by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 21,891 shares of the specialty chemicals company's stock valued at $2,706,000 after buying an additional 129 shares during the period. Raymond James Trust N.A. increased its stake in shares of Innospec by 7.9% in the third quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company's stock valued at $238,000 after buying an additional 155 shares during the period. Finally, Evergreen Capital Management LLC increased its stake in shares of Innospec by 8.6% in the second quarter. Evergreen Capital Management LLC now owns 2,421 shares of the specialty chemicals company's stock valued at $299,000 after buying an additional 192 shares during the period. Institutional investors own 96.64% of the company's stock.

Innospec Stock Performance

Shares of Innospec stock traded down $0.98 on Friday, hitting $116.16. The stock had a trading volume of 70,232 shares, compared to its average volume of 126,719. The stock has a 50 day moving average of $115.08 and a 200 day moving average of $117.90. Innospec Inc. has a twelve month low of $103.97 and a twelve month high of $133.71. The firm has a market capitalization of $2.90 billion, a P/E ratio of 20.27 and a beta of 1.09.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.35. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The company had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. During the same quarter in the prior year, the firm posted $1.59 earnings per share. The firm's revenue was down 4.5% compared to the same quarter last year. Equities analysts expect that Innospec Inc. will post 5.88 earnings per share for the current year.

Innospec Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th were paid a $0.79 dividend. This is a positive change from Innospec's previous Semi-Annual dividend of $0.72. This represents a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, November 18th. Innospec's dividend payout ratio is currently 27.57%.

Insider Activity

In related news, Director Milton C. Blackmore sold 1,035 shares of the business's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total value of $127,222.20. Following the transaction, the director now owns 9,028 shares in the company, valued at $1,109,721.76. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.52% of the company's stock.

About Innospec

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Should you invest $1,000 in Innospec right now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines